Manning & Napier Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 66,184 shares of the healthcare conglomerate's stock after selling 73,238 shares during the period. Manning & Napier Advisors LLC's holdings in UnitedHealth Group were worth $34,664,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Fort Washington Investment Advisors Inc. OH raised its holdings in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $515,000. Full Sail Capital LLC increased its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC increased its position in UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after buying an additional 12,550 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
UNH opened at $302.04 on Friday. The stock has a market cap of $273.99 billion, a P/E ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock's 50 day simple moving average is $359.15 and its 200 day simple moving average is $462.77. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the company posted $6.91 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.
Insider Buying and Selling at UnitedHealth Group
In other news, Director John H. Noseworthy bought 300 shares of the stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.
Wall Street Analyst Weigh In
UNH has been the topic of a number of recent research reports. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Truist Financial restated a "buy" rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Barclays dropped their price target on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Finally, Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $427.09.
View Our Latest Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report